BREAKING: AstraZeneca buys Alexion Pharmaceuticals for $39 billion, confirming Betaville's scoops...

Whoa! Alexion Pharmaceuticals, the US-listed pharmaceuticals stock, has just sold itself to FTSE 100-listed AsztraZeneca for $39 billion in cash and stock.

You need to register and sign in to read this content.